RecruitingPhase 1NCT06728189

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peking University Cancer Hospital & Institute
Intervention
CAR-NKT Cells treatment(biological)
Enrollment
13 enrolled
Eligibility
18-75 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

Suzhou Cure Genetics Biosciences Co., Limited.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06728189 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials